Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mangoceuticals, Inc. (MGRX)
USD0.37
-0.02 (-5.44%)
US NASDAQ Healthcare Medical - Healthcare Information Services
Address
15110 North Dallas Parkway 75248
Dallas, TX, US
Dallas, TX, US
CEO
Jacob D. Cohen
Website
mangorx.com
IPO
2023-03-21
CIK 1938046 ISIN US56270V2051
Description
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.37
-0.02 (-5.44%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
2.27
Float Shares
4.92M
Free Float %
48.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.97% | -4.44% | +26.47% | -19.63% | -61.26% | -41.89% | -80.28% | -97.37% | -99.28% | -99.28% | -99.28% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.37
DCF (Unlevered)
0.08
-77.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Quality scores
Altman Z-Score
-5.55
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%-26.0% Q1'26: -37.9% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+53.4% ★ Q1'26: +67.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-3,936.0% Q1'26: -1,932.3% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-4,504.2% Q1'26: -5,014.6% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-146.5% Q1'26: -100.1% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+408.9% Q1'26: +119.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.02× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
|---|---|
| Revenue |
731.5K
est: 17.9K (+3,991.6%)
|
| EBITDA |
-8.09M
|
| EBIT |
-8.12M
|
| Net Income |
-9.21M
|
| SGA |
5.42M
|
| EPS |
-8.58
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 5/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-4.93M
OE per share TTM
-0.48
Owner's Yield
-113.92%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
48.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
18
Total invested
297.6K
Insider transactions (90d)
0
Beneficial owners (>5%)
2
Beneficial owners (>5%)
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
18
+0 vs prev Q
New positions
5
Closed positions
5
Increased
10
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 194.5K +86.2K (+79.5%) | 70.0K -10.1K (-12.6%) | 1.93% +0.856 pp | 0.00% +0.000 pp | USD1.21 -70.2% | 6 qtrs — |
| 2 | IKARIAN CAPITAL, LLC | 138.1K +— (+0.0%) | 49.7K -52.5K (-51.3%) | 1.37% +0.000 pp | 0.00% -0.004 pp | USD0.74 -51.4% | 2 qtrs — |
| 3 | — | 123.0K +123.0K (+100.0%) | 44.3K +44.3K (+100.0%) | 1.22% +1.222 pp | 0.00% +0.000 pp | USD0.36 +0.0% | 1 qtrs NEW |
| 4 | JANE STREET GROUP, LLC | 72.7K +25.2K (+53.1%) | 26.2K -9.0K (-25.5%) | 0.72% +0.251 pp | 0.00% +0.000 pp | USD0.61 -41.0% | 2 qtrs — |
| 5 | VIRTU FINANCIAL LLC | 61.0K +27.6K (+82.4%) | 22.0K -3.0K (-12.0%) | 0.61% +0.274 pp | 0.00% 0.000 pp | USD0.57 -36.8% | 2 qtrs — |
| 6 | VANGUARD FIDUCIARY TRUST CO | 57.2K +57.2K (+100.0%) | 20.6K +20.6K (+100.0%) | 0.57% +0.568 pp | 0.00% +0.000 pp | USD0.36 +0.0% | 1 qtrs NEW |
| 7 | BOOTHBAY FUND MANAGEMENT, LLC | 38.4K +— (+0.0%) | 13.8K -14.6K (-51.3%) | 0.38% +0.000 pp | 0.00% 0.000 pp | USD0.74 -51.4% | 2 qtrs — |
| 8 | NORTHERN TRUST CORP | 37.6K +— (+0.0%) | 13.5K -14.3K (-51.3%) | 0.37% +0.000 pp | 0.00% +0.000 pp | USD1.47 -75.5% | 3 qtrs — |
| 9 | ACKERMAN CAPITAL ADVISORS, LLC | 34.5K +— (+0.0%) | 12.4K -13.1K (-51.3%) | 0.34% +0.000 pp | 0.00% -0.003 pp | USD2.42 -85.1% | 6 qtrs — |
| 10 | STONEX GROUP INC. | 16.0K +16.0K (+100.0%) | 5.8K +5.8K (+100.0%) | 0.16% +0.159 pp | 0.00% +0.000 pp | USD0.36 +0.0% | 1 qtrs NEW |
| 11 | XTX TOPCO LTD | 13.1K +13.1K (+100.0%) | 4.7K +4.7K (+100.0%) | 0.13% +0.131 pp | 0.00% +0.000 pp | USD0.36 +0.0% | 3 qtrs — |
| 12 | SUNBELT SECURITIES, INC. | 12.0K +— (+0.0%) | 4.3K -4.6K (-51.3%) | 0.12% +0.000 pp | 0.00% 0.000 pp | USD1.59 -77.4% | 3 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 11.8K +11.8K (+100.0%) | 4.2K +4.2K (+100.0%) | 0.12% +0.117 pp | 0.00% +0.000 pp | USD0.36 +0.0% | 1 qtrs NEW |
| 14 | CSENGE ADVISORY GROUP | 10.0K +— (+0.0%) | 3.6K -3.8K (-51.3%) | 0.10% +0.000 pp | 0.00% 0.000 pp | USD0.74 -51.4% | 2 qtrs — |
| 15 | ADVISOR GROUP HOLDINGS, INC. | 3.3K +400.0 (+13.9%) | 1.2K -952.0 (-44.6%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD1.76 -79.5% | 5 qtrs — |
| 16 | FORTITUDE FAMILY OFFICE, LLC | 1.3K +965.0 (+255.3%) | 484.00 +204.0 (+72.9%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD0.47 -23.4% | 2 qtrs — |
| 17 | MORGAN STANLEY | 1.0K +— (+0.0%) | 360.00 -380.0 (-51.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD0.74 -51.4% | 2 qtrs — |
| 18 | TOWER RESEARCH CAPITAL LLC (TRC) | 785.00 -217.0 (-21.7%) | 283.00 -458.0 (-61.8%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD0.74 -51.4% | 6 qtrs — |
| 19 | UBS GROUP AG | — -46.2K (-100.0%) | — -34.2K (-100.0%) | 0.00% -0.458 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 20 | CITIGROUP INC | — -1.0 (-100.0%) | — -1.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 21 | ARMISTICE CAPITAL, LLC | — -1.5M (-100.0%) | — -1.1M (-100.0%) | 0.00% -15.251 pp | 0.00% -0.014 pp | USD— | 2 qtrs SOLD |
| 22 | BANK OF AMERICA CORP /DE/ | — -107.0 (-100.0%) | — -79.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 51.7K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
143.3K
Cash buys
—
Cash sales
4.00
Net activity
-143,333
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 2,000,000 | 0.45 | 900.0K | 2,000,000 | D | ↗ |
| 2025-12-15 | JOHNSTON EUGENE M | Officer | S-Sale | D | Common Stock | 3,333 | 1.17 | 3.9K | 120,000 | D | ↗ |
| 2025-12-09 | JOHNSTON EUGENE M | Officer | S-Sale | D | Common Stock | 5,000 | 1.20 | 6.0K | 123,333 | D | ↗ |
| 2025-12-05 | JOHNSTON EUGENE M | Officer | S-Sale | D | Common Stock | 10,000 | 1.13 | 11.3K | 128,333 | D | ↗ |
| 2025-11-19 | Hamilton Alex P. | Director | S-Sale | D | Common Stock | 125,000 | 1.22 | 152.9K | 3,334 | D | ↗ |
| 2025-09-09 | MYERS KENNY | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 136,667 | D | ↗ |
| 2025-09-09 | JOHNSTON EUGENE M | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 138,334 | D | ↗ |
| 2025-09-09 | Hamilton Alex P. | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 126,667 | D | ↗ |
| 2025-09-09 | D'Alessio Lorraine Pamela | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 136,667 | D | ↗ |
| 2025-09-09 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Common Stock | 500,000 | 0.00 | — | 500,000 | D | ↗ |
| 2025-07-21 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Warrant to Purchase Common Stock | 50,000 | 1.85 | 92.5K | 50,000 | D | ↗ |
| 2025-06-05 | Cohen Jacob D. | Director / Officer / 10% Owner | G-Gift | A | Common Stock | 200,000 | 0.00 | — | 805,000 | D | ↗ |
| 2025-04-10 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Common Stock | 200,000 | 0.00 | — | 200,000 | D | ↗ |
| 2025-01-14 | Isaac Antonios | Director / Officer | — | — | Common Stock | 0 | 0.00 | — | 0 | D | ↗ |
| 2024-11-11 | JOHNSTON EUGENE M | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 38,334 | D | ↗ |
| 2024-08-26 | Cohen Jacob D. | Director / Officer / 10% Owner | G-Gift | A | Common Stock | 800,000 | 0.00 | — | 9,075,000 | — | ↗ |
| 2024-06-26 | Hamilton Alex P. | Director | S-Sale | D | Common Stock | 108,426 | 0.32 | 34.7K | 50,000 | — | ↗ |
| 2024-06-25 | Hamilton Alex P. | Director | S-Sale | D | Common Stock | 16,574 | 0.31 | 5.1K | 158,426 | — | ↗ |
| 2024-06-03 | MYERS KENNY | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 175,000 | — | ↗ |
| 2024-06-03 | Hammer Amanda Elizabeth | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 175,000 | — | ↗ |
| 2024-06-03 | Hamilton Alex P. | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 175,000 | — | ↗ |
| 2024-06-03 | D'Alessio Lorraine Pamela | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 175,000 | — | ↗ |
| 2024-06-03 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Common Stock | 800,000 | 0.00 | — | 800,000 | — | ↗ |
| 2023-12-28 | Cohen Jacob D. | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 125,000 | 0.32 | 40.0K | 1,250,000 | — | ↗ |
| 2023-10-03 | JOHNSTON EUGENE M | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 200,000 | — | ↗ |
| 2023-04-10 | Cohen Jacob D. | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 275,000 | 1.00 | 275.0K | 8,275,000 | — | ↗ |
| 2023-04-04 | Cohen Jacob D. | Director / Officer / 10% Owner | G-Gift | A | Common Stock | 8,000,000 | 0.00 | — | 8,000,000 | — | ↗ |
| 2023-03-20 | Cohen Jacob D. | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 8,000,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-68.5K
Shares Outstanding
10.13M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2023 | Jacob D. Cohen CEO and Chairman | 260.0K | — | — | 362.2K | — | 18.0K | 598.3K | 60.55% | ↗ |
| 2 | 2023 | Amanda Hammer COO | 105.4K | — | 75.0K | 149.0K | — | — | 329.4K | 68.00% | ↗ |
| 3 | 2023 | Jonathan Arango Former President, Secretary and Director | 120.0K | 5.0K | — | — | — | — | 125.0K | 0.00% | ↗ |
| 4 | 2023 | Eugene M. Johnston CFO | 14.0K | — | 42.5K | — | — | — | 56.5K | 75.22% | ↗ |
| 5 | 2022 | Jacob D. Cohen CEO and Chairman | 70.0K | — | 100.0K | 462.8K | — | — | 632.8K | 88.94% | ↗ |
| 6 | 2022 | Jonathan Arango Former President, Secretary and Director | 50.0K | — | 100.0K | 308.5K | — | — | 458.5K | 89.09% | ↗ |
| 7 | 2022 | Eugene M. Johnston CFO | — | — | 42.0K | — | — | — | 41.8K | 100.57% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jacob D. Cohen | Co-Founder, Chief Executive Officer & Chairman | 536.3K | male |
| Eugene Johnston | Chief Financial Officer | 46.0K | male |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MGRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
